HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS - ANVISA Registration 80943610220

Access comprehensive regulatory information for HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80943610220 and manufactured by SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. The registration is held by MINDRAY DO BRASIL COMÉRCIO E DISTRIBUIÇÃO DE EQUIPAMENTOS MÉDICOS LTDA. with validity until Dec 16, 2034.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT IRELAND DIAGNOSTIC DIVISION, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80943610220
2 Related Devices
Registration Details
ANVISA Registration Number: 80943610220
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Família Citomegalovírus IgG (CLIA)
Risk Class IV

Registration Details

80943610220

25351311887202495

09058456000187

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Dec 16, 2024

16/12/2034

09/18/2025 19:00:01

Família Citomegalovírus IgG (CLIA)
Risk Class IV

Registration Details

80943610220

25351311887202495

09058456000187

Dates and Status

Dec 16, 2024

16/12/2034

09/18/2025 19:00:01